Business Daily.
.
A+ R A-

The Conversation

imageReuters/Luke MacGregor

The approval in South Africa last year of the first new TB drug in 50 years was celebrated as a milestone in the fight against the global epidemic.

The drug – bedaquiline – is a new class of TB drug with the potential to tackle drug resistant strains of TB. Trials showed that, when combined with other...

Page 20969 of 27002

The Conversation


Business Daily Media